BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 82102)

  • 1. Multimodal therapy from stage-II breast cancer.
    Edelstyn GA; Bates T; Brinkley D; Kitchen G; MacRae KD; Nicol NT; Spittle M; Wheeler T
    Lancet; 1978 Nov; 2(8099):1092. PubMed ID: 82102
    [No Abstract]   [Full Text] [Related]  

  • 2. Multimodal therapy for histological stage-II breast cancer. Multicentre Breast Cancer Chemotherapy Group.
    Lancet; 1977 Aug; 2(8034):396-7. PubMed ID: 70600
    [No Abstract]   [Full Text] [Related]  

  • 3. An evaluation of five drug combination chemotherapy in the management of recurrent carcinoma of the breast.
    Lee JM; Abeloff MD; Lenhard RE; Baker RR
    Surg Gynecol Obstet; 1974 Jan; 138(1):77-80. PubMed ID: 4809006
    [No Abstract]   [Full Text] [Related]  

  • 4. Adjuvant therapy of stage II, III breast cancer.
    Buzdar AV; Gutterman JU; Blumenschein GR; Tashima CK; Hortobágyi GN; Yap HY; Hersh EM; Gehan EA
    Recent Results Cancer Res; 1978; 68():123-8. PubMed ID: 379930
    [No Abstract]   [Full Text] [Related]  

  • 5. Treatment of early breast cancer.
    Holland JF
    Lancet; 1978 Nov; 2(8100):1148-9. PubMed ID: 82703
    [No Abstract]   [Full Text] [Related]  

  • 6. [Chemotherapy using the CMF regimen (cyclophosphamide, methotrexate, and 5-fluorouracil) and the VAC protocol (vincristine, adriamycin and cyclophosphamide) in patients with advanced breast cancer].
    Glińska H; Zulichowska J; Radziszewska J; Sukiennik-Siuda M; Trabka E
    Nowotwory; 1987; 37(3):251-61. PubMed ID: 3438177
    [No Abstract]   [Full Text] [Related]  

  • 7. Five-drug therapy in advanced breast cancer: factors influencing toxicity and response.
    Davis HL; Ramirez G; Ellerby RA; Ansfield FJ
    Cancer; 1974 Aug; 34(2):239-45. PubMed ID: 4852055
    [No Abstract]   [Full Text] [Related]  

  • 8. Adriamycin combinations in advanced breast cancer. A Southwest Oncology Group Study.
    Tranum BL; McDonald B; Thigpen T; Vaughn C; Wilson H; Maloney T; Costanzi J; Bickers J; el Mawli NG; Palmer R; Hoogstraten B; Heilburn L; Rasmusen S
    Cancer; 1982 Mar; 49(5):835-9. PubMed ID: 7037152
    [No Abstract]   [Full Text] [Related]  

  • 9. [Preoperative polychemotherapy in the overall treatment of locally spread breast cancer (immediate results)].
    Sokolova IG; Vishniakova EG; Sviatukhina OV
    Vopr Onkol; 1980; 26(5):9-13. PubMed ID: 7385720
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Four drug combination cytotoxic chemotherapy following surgery for breast cancer.
    Edelstyn GA; Bates IS; Brinkley D; MacRae KD; Spittle H; Wheeler T
    Recent Results Cancer Res; 1978; 68():109-12. PubMed ID: 752851
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Short-course cyclical chemotherapy in advanced breast cancer.
    Edelstyn GA; Bates T; Brinkley D; MacRae KD; Spittle MF; Wheeler T
    Lancet; 1977 Mar; 1(8011):592. PubMed ID: 65673
    [No Abstract]   [Full Text] [Related]  

  • 12. [Results of 5-fluorouracil, methotrexate, cyclophosphamide and prednisone combination therapy in the treatment of advanced breast cancer].
    García Puche JL; Ballesteros P; Cueto J; Mendiola C; Rodríguez PA; Talavera MC
    Rev Clin Esp; 1979 Feb; 152(3):203-8. PubMed ID: 441472
    [No Abstract]   [Full Text] [Related]  

  • 13. A new CMF regimen.
    Demicheli R; Fossati V; Garusi GF
    Tumori; 1980 Dec; 66(6):743-8. PubMed ID: 7015645
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Evaluation of Picibanil as an adjuvant chemotherapeutic agent].
    Porwit-Ksiazek A; Kozłowicz-Gudzińska I; Zborzil J
    Nowotwory; 1982; 32(3):103-9. PubMed ID: 6760132
    [No Abstract]   [Full Text] [Related]  

  • 15. Cyclical combination chemotherapy in advanced breast cancer.
    Edelstyn GA; Marcrae KD
    Ann R Coll Surg Engl; 1974 Jun; 54(6):275-6. PubMed ID: 4833779
    [No Abstract]   [Full Text] [Related]  

  • 16. Combination chemotherapy in disseminated carcinoma of the breast.
    Kaufman S; Goldstein M
    Surg Gynecol Obstet; 1973 Jul; 137(1):83-6. PubMed ID: 4714324
    [No Abstract]   [Full Text] [Related]  

  • 17. Combination chemotherapy in advanced breast cancer. A report of the Working Party of the Multicentre Cancer Chemotherapy Group.
    Spittle MF; Bates TD; Kitchen G; Nicol NT; Wheeler T; Edelstyn G; MacRae KD; Ostrowski MJ
    Clin Oncol; 1980 Jun; 6(2):153-7. PubMed ID: 7408282
    [No Abstract]   [Full Text] [Related]  

  • 18. Editorial: Major advance in breast-cancer therapy.
    Holland JF
    N Engl J Med; 1976 Feb; 294(8):440-1. PubMed ID: 1246311
    [No Abstract]   [Full Text] [Related]  

  • 19. Scandinavian trials with a short postoperative course versus a 12-cycle course.
    Nissen-Meyer R; Høst H; Kjellgren K; Månsson B; Norin T
    Recent Results Cancer Res; 1984; 96():48-54. PubMed ID: 6396779
    [No Abstract]   [Full Text] [Related]  

  • 20. Single-drug vs combination cytotoxic chemotherapy in advanced breast cancer: a randomized study.
    Carmo-Pereira J; Costa FO; Henriques E
    Eur J Cancer (1965); 1980 Dec; 16(12):1621-5. PubMed ID: 7014228
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.